{"public_id":"cl_978f041afe5013ab913756dfeff96caa","status":"active","superseded_by_public_id":null,"corpus_id":252457006,"text":"IFNγ concentrations were higher in COVID-19 convalescents than in naïve participants at both timepoints—before and 21 days after the BNT162b2 booster.","confidence":0.92,"paper":{"corpus_id":252457006,"title":"An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results","url":"https://sah.borca.ai/papers/252457006"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.92,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0ca15246c0c120a4b5e953b2c5c80479","name":"COVID-19 convalescents","description":"Study participants who had a prior documented COVID-19 infection before enrollment, forming one of the two comparison cohorts for immune response analysis.","types":["participant group"],"url":"https://sah.borca.ai/concepts/co_0ca15246c0c120a4b5e953b2c5c80479"},{"public_id":"co_2b1cbac5fc78275535a7bd59e4ee198b","name":"interferon-gamma","description":"A cytokine released by sensitized T cells upon antigen stimulation, measured here as the primary IGRA readout to quantify T-cell immune responses to SARS-CoV-2 vaccination.","types":["cytokine","biomarker"],"url":"https://sah.borca.ai/concepts/co_2b1cbac5fc78275535a7bd59e4ee198b"},{"public_id":"co_f9502c5d896e56833114651ad9d82974","name":"Interferon-Gamma Release Assay","description":"A whole-blood test that quantifies IFNγ released by antigen-stimulated T cells, used here to assess SARS-CoV-2-specific cell-mediated immunity before and after the booster dose.","types":["diagnostic test","measurement technique"],"url":"https://sah.borca.ai/concepts/co_f9502c5d896e56833114651ad9d82974"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_978f041afe5013ab913756dfeff96caa"}